/Companies

PeproMene Bio

Irvine, US · Founded 2016 · California corporation · 1 known investors

Find your way into PeproMene Bio

Sign up to see every warm intro you have to PeproMene Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the PeproMene Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

HL
Hyukjong LeeNamed on SEC filing
ST
Sun Tae HwangNamed on SEC filing
YR
Young Rae ChoiNamed on SEC filing
HW
Hong Woo KimNamed on SEC filing
YK
Yung Ki ParkNamed on SEC filing

Investors · 1

Also in the syndicate · 1

Institute for Follicular Lymphoma Innovationlead

Reported raises · per SEC filings

Form D private placements

$40.2M disclosed across 1 of 2 rounds · 2017–2024

▶$40.2MraisedJun 2018 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hyukjong LeeDirector
  • Sun Tae HwangDirector
  • Young Rae ChoiDirector
  • Hong Woo KimExecutive Officer, Director
  • Yung Ki ParkExecutive Officer, Director
Offering amount
$40.2M
Amount sold
$40.2M
Minimum investment
$1K
First sale
Jul 2017
Incorporated
Corporation, California, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has PeproMene Bio raised?
PeproMene Bio has disclosed $40.2M raised across 1 of its 2 known rounds.
Where is PeproMene Bio headquartered?
PeproMene Bio is headquartered in Irvine, US.